About Matt Schiller
Matt Schiller is an experienced business development professional with over 20 years of expertise in global licensing and commercial development.
Known information
Matt Schiller currently serves as the Head of Business Development, bringing over two decades of experience in the field. He has held several significant roles, including Director of Global Licensing & Business Development in Immunology at EMD Serono, and Head of Licensing at Cell Signaling Technology. Previously, Schiller was the Vice President of Business Development at Ensemble Discovery and the Senior Director of Business Development at Critical Therapeutics. He holds a Bachelor of Science in Chemistry from the University of South Florida.
About NexImmune
NexImmune is a biotechnology company that develops innovative technologies to direct cell-mediated immune responses for treating a variety of diseases, including cancer, infectious, and autoimmune diseases.